Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists
- PMID: 2532457
- DOI: 10.1016/0002-9343(89)90087-9
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists
Abstract
The biologic actions of the cardiac peptide hormone atrial natriuretic peptide (ANP) of vasorelaxation, diuresis and natriuresis, suppression of aldosterone, vasopressin release, and thirst are the opposite of those of the renin angiotensin system. This close relationship is further strengthened by the complementary localization of their receptors in the brain, adrenal gland, vasculature, and kidney. In many physiologic situations including postural changes, volume expansion, water immersion, high altitude, and lower body negative pressure, the plasma levels of ANP and angiotensin II change inversely. In congestive heart failure, renin and aldosterone levels may initially be suppressed by high levels of ANP. Similarly the low renin levels associated with increasing age and with elderly hypertensive patients, may be the result of the elevation of plasma ANP that occurs with aging. ANP may thus be the endogenous antagonist of the renin angiotensin aldosterone system. These two opposing systems allow fine-tuning of volume and pressure by the body.
Similar articles
-
Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide.J Hypertens. 2008 Feb;26(2):303-11. doi: 10.1097/HJH.0b013e3282f240a7. J Hypertens. 2008. PMID: 18192845
-
[Does atrial antipressor natriuretic peptide play a pathophysiological role?].Schweiz Med Wochenschr. 1987 Dec 5;117(49):1930-7. Schweiz Med Wochenschr. 1987. PMID: 2962281 Review. German.
-
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Clin Physiol. 2001 Nov;21(6):661-72. doi: 10.1046/j.1365-2281.2001.00371.x. Clin Physiol. 2001. PMID: 11722473 Review.
-
Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.J Mol Cell Cardiol. 1994 Apr;26(4):527-37. doi: 10.1006/jmcc.1994.1063. J Mol Cell Cardiol. 1994. PMID: 8072008
-
Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis.Annu Rev Med. 1986;37:397-414. doi: 10.1146/annurev.me.37.020186.002145. Annu Rev Med. 1986. PMID: 2939792 Review.
Cited by
-
"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".Channels (Austin). 2019 Dec;13(1):1-16. doi: 10.1080/19336950.2018.1547611. Channels (Austin). 2019. PMID: 30424709 Free PMC article.
-
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.Semin Nephrol. 2013 May;33(3):265-76. doi: 10.1016/j.semnephrol.2013.04.007. Semin Nephrol. 2013. PMID: 23953804 Free PMC article. Review.
-
Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome.Arch Med Sci. 2011 Apr;7(2):247-56. doi: 10.5114/aoms.2011.22075. Epub 2011 May 17. Arch Med Sci. 2011. PMID: 22291764 Free PMC article.
-
Pathophysiology of Hyponatremia in Children.Front Pediatr. 2017 Oct 16;5:213. doi: 10.3389/fped.2017.00213. eCollection 2017. Front Pediatr. 2017. PMID: 29085814 Free PMC article. Review.
-
Weight loss, saline loading, and the natriuretic peptide system.J Am Heart Assoc. 2015 Jan 16;4(1):e001265. doi: 10.1161/JAHA.114.001265. J Am Heart Assoc. 2015. PMID: 25595796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources